LumiraDx Submits First 510 Application to the FDA for COVID Ultra Test
| LMDXDelisted Stock | USD 0.42 0.02 4.55% |
Slightly above 61% of LumiraDx's investor base is looking to short. The analysis of current outlook of investing in LumiraDx suggests that many traders are alarmed regarding LumiraDx's prospects. LumiraDx's investing sentiment can be driven by a variety of factors including economic data, LumiraDx's earnings reports, geopolitical events, and overall market trends.
LumiraDx |
LumiraDx submits a traditional 510 Dual Submission for LumiraDx SARS-CoV-2 Ag Ultra with CLIA Waiver for the commercial distribution at point of care of...
Read at globenewswire.com
 |
LumiraDx Fundamental Analysis
We analyze LumiraDx's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of LumiraDx using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of LumiraDx based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Valuation
Current Valuation Comparative Analysis
LumiraDx is currently under evaluation in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
LumiraDx Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with LumiraDx stock to make a market-neutral strategy. Peer analysis of LumiraDx could also be used in its relative valuation, which is a method of valuing LumiraDx by comparing valuation metrics with similar companies.
Peers
LumiraDx Related Equities
| SHC | Sotera Health | 1.65 | ||||
| XGN | Exagen | 1.41 | ||||
| FONR | Fonar | 0.87 | ||||
| BDSX | Biodesix | 0.68 | ||||
| BNR | Burning Rock | 1.22 | ||||
| ENZ | Enzo Biochem | 1.35 | ||||
| SERA | Sera Prognostics | 7.56 | ||||
| DRIO | DarioHealth Corp | 12.50 |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Consideration for investing in LumiraDx Stock
If you are still planning to invest in LumiraDx check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the LumiraDx's history and understand the potential risks before investing.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Commodity Directory Find actively traded commodities issued by global exchanges |